Dr. Zvi J. Schiffman, MD

Dr. Schiffman practices at HMU Surgical Center in Houston, Texas.

Dr. Schiffman's NPI, 1528036779, was assigned on March 14, 2006. Dr. Schiffman graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1974. Dr. Schiffman holds Texas license G7330.

Dr. Schiffman's primary practice is HMU Surgical Center, at 4219 Richmond Ave, Suite 100, Houston, TX 77027. The practice phone is (713) 634-4433.

Dr. Schiffman's primary practice is HMU Surgical Center in Houston, Texas. Dr. Schiffman is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Houston Metro Urology. Dmand AI also links Dr. Schiffman to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schiffman practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Schiffman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Schiffman is board certified in urology by the American Board of Urology. Dmand AI has Dr. Schiffman's licenses on file in 2 states: Texas and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Schiffman treats.

CMS data shows 3,837 Medicare services from Dr. Schiffman across 18 procedure codes in 2024, for 440 Medicare patients. Medicare paid $145,816 for them.

CMS counts 440 Medicare patients who saw Dr. Schiffman in 2024. The largest group is 65 to 74, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schiffman's median patient age at 71, with 13% women.

In 2024, Dr. Schiffman wrote 2,740 Medicare Part D claims for 664 patients. 91% of them were for generic drugs. CMS names the drug for 2,658 of them, across 23 drugs with 11 or more claims each, at $1,404,313 in total drug cost. In 2023, CMS named 2,547 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Schiffman for performance year 2024, reported as part of a group. Dr. Schiffman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schiffman as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Schiffman in 2014. The most frequent topics are Carcinoma, Transitional Cell and Urinary Bladder Neoplasms. Dr. Schiffman has published most often in Urology.

Dmand AI links Dr. Schiffman to 1 clinical trial.

CMS Open Payments shows 912 general payments to Dr. Schiffman from 77 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Valeant Pharmaceuticals International paid the most, $23,341. It also lists 2 research payments totaling $660 from 2024 to 2025.

Dmand AI lists 3 awards for Dr. Schiffman, most recently CMS Stage 1 2012 in 2011.

Dr. Schiffman graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1974. Dr. Schiffman is a member of ACS.

Dr. Schiffman is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.